
Brittany N. Allen
Examiner (ID: 18845, Phone: (571)270-3566 , Office: P/2169 )
| Most Active Art Unit | 2169 |
| Art Unit(s) | 2169 |
| Total Applications | 439 |
| Issued Applications | 166 |
| Pending Applications | 50 |
| Abandoned Applications | 232 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16932777
[patent_doc_number] => 20210198666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/997022
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997022
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997022 | ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF | Aug 18, 2020 | Abandoned |
Array
(
[id] => 17852215
[patent_doc_number] => 20220282257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => METHOD OF MODULATING ADIPOSITY
[patent_app_type] => utility
[patent_app_number] => 17/636481
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33026
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17636481
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/636481 | METHOD OF MODULATING ADIPOSITY | Aug 18, 2020 | Pending |
Array
(
[id] => 17874259
[patent_doc_number] => 11446250
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Lyophilization of RNA
[patent_app_type] => utility
[patent_app_number] => 16/995224
[patent_app_country] => US
[patent_app_date] => 2020-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 8
[patent_no_of_words] => 34061
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 255
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16995224
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/995224 | Lyophilization of RNA | Aug 16, 2020 | Issued |
Array
(
[id] => 16688702
[patent_doc_number] => 20210071178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => TARGETED TRANS-SPLICING USING CRISPR/CAS13
[patent_app_type] => utility
[patent_app_number] => 16/994230
[patent_app_country] => US
[patent_app_date] => 2020-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19729
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16994230
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/994230 | Targeted trans-splicing using CRISPR/Cas13 | Aug 13, 2020 | Issued |
Array
(
[id] => 17838067
[patent_doc_number] => 20220275372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => CONJUGATE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/631654
[patent_app_country] => US
[patent_app_date] => 2020-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631654
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/631654 | CONJUGATE AND USES THEREOF | Aug 6, 2020 | Pending |
Array
(
[id] => 18187756
[patent_doc_number] => 11578328
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Interfering RNA molecules
[patent_app_type] => utility
[patent_app_number] => 16/988226
[patent_app_country] => US
[patent_app_date] => 2020-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 47
[patent_no_of_words] => 18626
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16988226
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/988226 | Interfering RNA molecules | Aug 6, 2020 | Issued |
Array
(
[id] => 17968442
[patent_doc_number] => 11485958
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-01
[patent_title] => HSD17B13 variants and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/942386
[patent_app_country] => US
[patent_app_date] => 2020-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 37
[patent_no_of_words] => 89480
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16942386
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/942386 | HSD17B13 variants and uses thereof | Jul 28, 2020 | Issued |
Array
(
[id] => 18685414
[patent_doc_number] => 11781137
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-10
[patent_title] => Variant RNAi
[patent_app_type] => utility
[patent_app_number] => 16/941303
[patent_app_country] => US
[patent_app_date] => 2020-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 40
[patent_no_of_words] => 35508
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16941303
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/941303 | Variant RNAi | Jul 27, 2020 | Issued |
Array
(
[id] => 17792471
[patent_doc_number] => 20220251562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => Anti-CD3 Aptamers for Use in Cell Targeting and Labeling
[patent_app_type] => utility
[patent_app_number] => 17/629943
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629943
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/629943 | Anti-CD3 Aptamers for Use in Cell Targeting and Labeling | Jul 26, 2020 | Pending |
Array
(
[id] => 17619014
[patent_doc_number] => 11338041
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => Exon skipping oligomer conjugates for muscular dystrophy
[patent_app_type] => utility
[patent_app_number] => 16/938278
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 35
[patent_no_of_words] => 35350
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/938278 | Exon skipping oligomer conjugates for muscular dystrophy | Jul 23, 2020 | Issued |
Array
(
[id] => 17974401
[patent_doc_number] => 11491238
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Exon skipping oligomer conjugates for muscular dystrophy
[patent_app_type] => utility
[patent_app_number] => 16/938274
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 35
[patent_no_of_words] => 35378
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938274
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/938274 | Exon skipping oligomer conjugates for muscular dystrophy | Jul 23, 2020 | Issued |
Array
(
[id] => 17783583
[patent_doc_number] => 11406688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Compositions and methods for the systemic treatment of arthritis
[patent_app_type] => utility
[patent_app_number] => 16/947126
[patent_app_country] => US
[patent_app_date] => 2020-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 6212
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16947126
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/947126 | Compositions and methods for the systemic treatment of arthritis | Jul 19, 2020 | Issued |
Array
(
[id] => 18004954
[patent_doc_number] => 20220363720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => MELANOPHILIN ANTISENSE OLIGONUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 17/626981
[patent_app_country] => US
[patent_app_date] => 2020-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9543
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 276
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626981
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/626981 | MELANOPHILIN ANTISENSE OLIGONUCLEOTIDES | Jul 13, 2020 | Pending |
Array
(
[id] => 16728142
[patent_doc_number] => 20210095289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE
[patent_app_type] => utility
[patent_app_number] => 16/927559
[patent_app_country] => US
[patent_app_date] => 2020-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48587
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16927559
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/927559 | COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE | Jul 12, 2020 | Abandoned |
Array
(
[id] => 17895445
[patent_doc_number] => 20220305107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND HBV-TARGETING RNAi
[patent_app_type] => utility
[patent_app_number] => 17/596764
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17596764
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/596764 | COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND HBV-TARGETING RNAi | Jun 17, 2020 | Abandoned |
Array
(
[id] => 18084298
[patent_doc_number] => 11534405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Dry powder composition comprising long-chain RNA
[patent_app_type] => utility
[patent_app_number] => 16/904993
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 29079
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904993
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/904993 | Dry powder composition comprising long-chain RNA | Jun 17, 2020 | Issued |
Array
(
[id] => 16555828
[patent_doc_number] => 20210000976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => EXOSOME TRANSFER OF NUCLEIC ACIDS TO CELLS
[patent_app_type] => utility
[patent_app_number] => 16/905719
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4889
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16905719
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/905719 | EXOSOME TRANSFER OF NUCLEIC ACIDS TO CELLS | Jun 17, 2020 | Abandoned |
| 16/902198 | SELF-REPLICATING CELL SELECTIVE GENE DELIVERY COMPOSITIONS, METHODS, AND USES THEREOF | Jun 14, 2020 | Abandoned |
Array
(
[id] => 17776855
[patent_doc_number] => 20220243204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => TREATMENT OF HEART FAILURE IN HUMAN SUBJECTS
[patent_app_type] => utility
[patent_app_number] => 17/618801
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17618801
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/618801 | TREATMENT OF HEART FAILURE IN HUMAN SUBJECTS | Jun 11, 2020 | Issued |
Array
(
[id] => 18871391
[patent_doc_number] => 11859180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Antisense oligonucleotide compositions
[patent_app_type] => utility
[patent_app_number] => 16/896752
[patent_app_country] => US
[patent_app_date] => 2020-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 32231
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16896752
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/896752 | Antisense oligonucleotide compositions | Jun 8, 2020 | Issued |